UK med-tech expert warns: “AI scribe tools must prioritise patient safety and data privacy”

Editorial Brief
At a glance: AI-assisted overview, optimised for journalists, search & news aggregators
Press Release

UNITED KINGDOM - June 25, 2025

A leading med-tech expert has issued a stark warning about the risks posed to patient safety and data privacy by widespread AI tools used by GPs in NHS consultations, which were the subject of NHS guidance shared this week.

Dr Andrew Whiteley – a former GP and founder of Lexacom, one of the UK’s longest-established developers of next generation speech-powered products – is calling for urgent action to ensure Ambient Voice Technology (AVT) tools meet NHS compliance standards before being deployed in patient care.

“Harnessing efficiency gains in primary care via AI is important, but this should not come at the cost of patient safety or data security”, says Dr Whiteley. “The reality is that GPs are increasingly under pressure and time poor. Despite this, there is a clear hunger to interrogate emerging solutions, and embrace new systems that could be transformative for the clinicians themselves, and for patients too. So the task at hand is to offer them guidance to make choices that are compliant with NHS regulations.

“In particular, any solution that processes patient consultations through AI must, at minimum, automatically redact personal data before processing – otherwise the risk of breaches is simply too great. And crucially, we believe data must be stored in the United Kingdom, where it is protected under UK law – providing greater clarity and reassurance around accountability and legal safeguard.”

Lexacom leads with NHS-compliant solution

While several unapproved AVT tools are currently in use, often on free trials or without formal commissioning, Lexacom is one of the few providers meeting every NHS assurance standard. These include:

  • MHRA Class 1 medical device classification
  • Clinical safety accreditation
  • Cyber Essentials Plus certification
  • Data Protection Impact Assessment (DPIA) and full integration with NHS systems

Developed in direct response to growing concerns around AI safety in healthcare, Lexacom launched Patient Shield earlier this year. A UK-first, it safeguards patient confidentiality by automatically redacting personal data before AI involvement – protecting both patients and clinicians from risk.

Public trust is at risk

A recent Lexacom-commissioned YouGov survey found:

  • 73% of UK adults do not trust big tech companies with their personal health data
  • Over 8,000 data breaches have been reported across the UK health sector since 2019

“There’s a tension we must address,” adds Dr Whiteley. “The public is open to AI in healthcare – but only if it’s used responsibly. Trust is fragile. We owe it to patients to show that innovation can go hand-in-hand with robust protections.”

With more than 60% of UK GPs already using Lexacom’s documentation tools, the company has a 25-year track record of delivering NHS-compliant innovation – from mobile dictation in 2013 to cloud-based speech recognition in 2016. Its latest advancement marks another milestone in digital documentation safety.

Notes to editors

Lexacom is a leading developer of next generation speech-powered products. Relied upon by clinicians around the world for more than 25 years, its comprehensive range of workflow management, ambient AI, speech recognition and digital dictation solutions help organisations work more quickly, reliably, and efficiently. Drawing on decades of professional experience, its medical dictation and workflow solutions, built in line with stringent NHS standards, help improve efficiency, accuracy, and the patient journey in the healthcare sector.

Get more news like this

Get more news like this on Google. Set News By Wire as a ‘Preferred News Source’ to get quicker access to news that’s important.

All done!
Thank you for subscribing.

Email Subscription